News

Transplant coordinators’ perception of generic immunosuppressants

Published on 2014/02/04

Transplant coordinators associate the availability of multiple generic immunosuppression therapies with increased patient confusion, according to a study by Parker and co-authors. Immunosuppression...

4 views

Read more →

More immunogenicity data needed for biosimilar mAbs

Published on 2014/01/30

Eight therapeutic monoclonal antibodies (mAbs) will lose EU and US patent protection before 2020, making way for a new class of biosimilar. The promise of biosimilar mAbs is enticing, but these are mo...

0 views

Read more →

Health Canada announces plans to tackle drug shortages

Published on 2014/01/28

Health Canada announced on 13 September 2013 plans, which it is hoped will help to address problems the country has been having with shortages of drugs in Canada. Alberta’s Health Minister, Fred Ho...

1 views

Read more →

Use of generic anti-asthmatic drugs in Morocco

Published on 2014/01/23

Asthma is a serious public health problem in Morocco. However, due to low income and lack of healthcare coverage in the country many of Morocco’s citizens do not have access to anti-asthmatic drugs....

5 views

Read more →

UK biosimilars uptake lower than in some other EU countries

Published on 2014/01/21

Use of biosimilars in the UK is lower than might be expected when looking at the use of generics in the UK, and it is lower than in some other European countries. Biosimilars in the UK make up only 3...

9 views

Read more →

Challenges and opportunities for anticancer mAbs

Published on 2014/01/16

Several best-selling monocloncal antibodies (mAbs) are due to lose patent protection; presenting regulatory authorities with a complex set of challenges as they prepare for the arrival of novel biosim...

1 views

Read more →

India’s pharma moving from generics to niche drugs

Published on 2014/01/14

Indian pharmaceutical companies will increasingly move away from the overcrowded and competitive area of generics and invest more R & D spending in niche drugs, according to a new report. India...

12 views

Read more →

South Africa introduces new patent policy

Published on 2014/01/09

South Africa has become the latest country to examine its patent laws with a view to curbing patent evergreening and increasing production of generics. The South African Government Department of Trad...

1 views

Read more →

Therapeutic substitution could save Americans money

Published on 2014/01/07

Substituting more expensive brand-name drugs with generics or therapeutic substitutes, could lead to significant savings for Medicare Part D beneficiaries, according to US researchers. Researchers ...

3 views

Read more →

Implications of the changes in venlafaxine utilization in Sweden following generics

Published on 2014/01/02

Godman and co-authors review the changes in the utilization of venlafaxine post generics. This includes the limited influence on utilization post generics with no specific demand-side measures. This c...

0 views

Read more →

Assessment of efficacy and safety of biosimilars in rheumatology

Published on 2013/12/31

During the last decade, the availability of biological therapies has revolutionized the treatment of rheumatoid arthritis. Biologicals, unlike small-molecule chemical drugs, are extremely complex mole...

3 views

Read more →

How to avoid drug shortages

Published on 2013/12/26

Despite FDA having made progress in recent years to combat drug shortages, the issue is still a major problem for the agency. This very fact led to the agency requesting public comment on the subject ...

1 views

Read more →